drugset / Trial / NCT06794294

Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells on Patients With Rotator Cuff Disease

NCT06794294 ↗

Phase 1/2 Recruiting 21 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate safety and efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease

Timeline

Start
2025-01-17
Primary completion
2027-01
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject allogenic Umbilical Cord-derived Mesenchymal Stem Cell Cell therapy 1e+07 cells Other
Subject allogenic Umbilical Cord-derived Mesenchymal Stem Cell Cell therapy 5e+07 cells Other
Subject allogenic Umbilical Cord-derived Mesenchymal Stem Cell Cell therapy 1e+08 cells Other

Indications